(NBIX) Neurocrine Biosciences - Performance -15.3% in 12m
Compare NBIX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
1.91%
#34 in Peer-Group
Rel. Strength
30.64%
#5304 in Stock-Universe
Total Return 12m
-15.30%
#55 in Peer-Group
Total Return 5y
-3.33%
#38 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 39.2 |
| P/E Forward | 23.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 153.29 USD |
| 52 Week Low | 87.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.29 |
| Buy/Sell Signal +-5 | 0.93 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NBIX (-15.3%) vs XBI (-16.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
2.76% | 15% | 144% | 84.8 | 16.3 | 0.42 | -26.0% | 14.2% |
| UTHR NASDAQ United Therapeutics |
6.71% | 11.5% | 155% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
| GILD NASDAQ Gilead Sciences |
-5.05% | 55.4% | 64.3% | 20.4 | 12.2 | 0.2 | 28.0% | -3.71% |
| AMGN NASDAQ Amgen |
-8% | -12.3% | 35% | 24.7 | 13 | 0.9 | 0.60% | 41% |
| LONN SW Lonza |
5.88% | 7.55% | 26.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
| BIM PA Biomerieux |
- | 24.9% | -3% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
9.06% | 26.2% | 1.24% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
25.1% | -15.3% | -3.33% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
| Total Return (including Dividends) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 25.07% | 1.36% | 9.83% |
| 3 Months | 5.53% | -15.05% | -3.15% |
| 12 Months | -15.30% | -16.10% | 12.87% |
| 5 Years | -3.33% | -26.28% | 115.27% |
| Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.7% | 5.6% | 97.1% |
| 3 Months | -22.7% | -77.9% | -46.6% |
| 12 Months | -58.9% | -58.5% | 47.9% |
| 5 Years | 51.7% | -54% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #29 | 23.40% | 13.88% |
| 3 Month | #25 | 24.22% | 8.96% |
| 12 Month | #56 | 0.96% | -24.96% |
| 5 Years | #37 | 31.13% | -55.09% |
FAQs
Does Neurocrine Biosciences (NBIX) outperform the market?
Yes,
over the last 12 months NBIX made -15.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -16.10%.
Over the last 3 months NBIX made 5.53%, while XBI made -15.05%.
Performance Comparison NBIX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NBIX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.2% | 15.2% | 1% | -28% |
| US NASDAQ 100 | QQQ | -4% | 11.7% | -2.5% | -31% |
| German DAX 40 | DAX | 1.1% | 13.9% | -20.5% | -40% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.3% | 18.8% | 2.7% | -24% |
| Hongkong Hang Seng | HSI | -0.8% | 10.1% | -9.2% | -26% |
| India NIFTY 50 | INDA | -3.9% | 18% | -1.6% | -21% |
| Brasil Bovespa | EWZ | 0.4% | 12.4% | -4.9% | -11% |
NBIX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.2% | 15.3% | -4.4% | -39% |
| Consumer Discretionary | XLY | -4.7% | 10.9% | 0.9% | -37% |
| Consumer Staples | XLP | 2.6% | 24.9% | -0.4% | -23% |
| Energy | XLE | -2.6% | 16.8% | 10.6% | -9% |
| Financial | XLF | -0.5% | 16.6% | -1.2% | -39% |
| Health Care | XLV | 5.1% | 30.3% | 9.7% | -6% |
| Industrial | XLI | -2.2% | 12.6% | -0.6% | -30% |
| Materials | XLB | 0.2% | 18.5% | 7.1% | -11% |
| Real Estate | XLRE | 2% | 20.9% | 4.2% | -26% |
| Technology | XLK | -5.3% | 8.4% | -0.5% | -26% |
| Utilities | XLU | 1.2% | 20.8% | -1.4% | -30% |
| Aerospace & Defense | XAR | -2.3% | 10.8% | -11.6% | -47% |
| Biotech | XBI | 2.9% | 23.7% | 17.9% | 1% |
| Homebuilder | XHB | -0.2% | 16.2% | 16.2% | -6% |
| Retail | XRT | -3.7% | 10.2% | 5.4% | -14% |
NBIX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.7% | 23.4% | 5.51% | -4% |
| Natural Gas | UNG | 9.4% | 28.3% | -23.2% | -11% |
| Gold | GLD | 4.6% | 25.1% | -23.5% | -50% |
| Silver | SLV | 1.8% | 24.4% | -5% | -24% |
| Copper | CPER | -0.1% | 24.2% | -11.9% | -13% |
NBIX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.3% | 26.7% | 4.8% | -13% |
| iShares High Yield Corp. Bond | HYG | 1.3% | 22% | -0.7% | -24% |